• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

The FDA Recommends Ending the Ban on Blood Donations from Gay Men

January 7, 2015

171136170The FDA recently recommended ending the lifetime ban on blood donations from men who have had sex with men. The FDA is in the process of drafting guidance to change the deferral period to one year since the last sexual contact, which is consistent with other activities that pose similar risks of transfusion-transmitted infections. This change is supported by scientific evidence and recommendations from the AABB, American’s Blood Centers, the American Red Cross and also the Department of Health of Human Services Advisory Committee on Blood and Tissue Safety and Availability.

Reference
1. FDA Statement. FDA Commissioner Margaret A. Hamburg’s statement on FDA’s blood donor deferral policy for men who have had sex with men, December 23, 2014. Accessed online January 7, 2015.  http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm427843.htm

Filed Under

  • Blood Donation
  • News
  • Policy and Guidelines

Recommended

  • RBC Alloimmunization is a Predictor of HLA Alloimmunization

  • Platelet Extracellular Vesicles Formed During Storage May Be Causative Agents in Non-Antibody-Mediated TRALI

  • Increasing Data Available for Plasma Transfusion Indications

Show Comments

Comments on this article are closed.

Get the latest news. Subscribe to our mailing list. Sign Up

Primary Sidebar

Latest News

  • Mitochondrial DNA Acts as a “First Hit” for Antibody-Mediated TRALI

  • Liberal or Restrictive Transfusion Thresholds for Surgery Patients with High Cardiac Risk

  • Iron Supplementation for Blood Donors Based on Ferritin Levels

  • Impact of Individual Donor Assessment Deferral Changes on Donor HIV, HBV, HCV, and Syphilis Prevalence

    Question of the Day

    Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley